about
Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughoutCrystal structure of the C1 domain of cardiac myosin binding protein-C: implications for hypertrophic cardiomyopathySmall molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.Calcium-dependent conformational changes in inositol trisphosphate receptors.IP(3) receptors: the search for structure.High-resolution cryo-EM proteasome structures in drug development.Identification of functionally critical residues in the channel domain of inositol trisphosphate receptorsStructure- and function-based design of Plasmodium-selective proteasome inhibitorsThe cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.Recombinant expression, reconstitution and structure of human anaphase-promoting complex (APC/C).Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core.Building a pseudo-atomic model of the anaphase-promoting complexStructure of the human 26S proteasome: subunit radial displacements open the gate into the proteolytic coreThree-dimensional structure of Chlamydomonas reinhardtii and Synechococcus elongatus photosystem II complexes allows for comparison of their oxygen-evolving complex organization.Proceedings of the third CCP-EM Spring SymposiumCovalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agentsCharacterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes
P50
Q24644829-6ACE5244-C7C2-4D7B-8227-F0A884193593Q27650183-16735465-7CB0-4DA2-8336-90E2B9C54B35Q33291059-DE84BDFE-EB74-40F8-A5E6-0E6B12154E93Q34042834-D972C5C1-79E0-4B90-8A07-5EB8D41E803FQ34313146-6971685F-8FF4-4009-B65F-821A778A4A31Q36392578-F05B8C24-94FD-4582-B5B4-291E66B6D6C2Q36481838-2A1F1484-472A-4E94-AA02-86D2CB25B7D6Q36584903-7F232E1A-499E-4A14-AAA8-8FD85A3F2A32Q38861425-B85BB6EE-A205-413C-9A89-C9E3E6167BCCQ39256977-AD3C69A7-40A9-4B0C-99C1-2E2D94E6B0DBQ40467514-F2338079-97B0-4CAF-B6D6-B0C6CE47DE37Q41604784-D825E0EB-A843-4963-9A77-EE9CF34B5193Q41832647-AF760319-76BF-401A-BDF1-B136AC2A1195Q42114358-3CF0369B-B6CC-42A1-A2F0-577A319C2A31Q43027584-81D97902-AF0B-4CA0-A861-DE47C14D4CADQ89000617-827B94B1-2736-486B-96D2-DEE569365A38Q92563101-A024AD78-1436-47BC-AB6C-F7274349788BQ93034953-A445CC3E-DEF0-4A78-89C2-7F5C3D018FB1
P50
description
researcher
@en
wetenschapper
@nl
name
Paula Da Fonseca
@en
da Fonseca P
@nl
type
label
Paula Da Fonseca
@en
da Fonseca P
@nl
altLabel
da Fonseca P
@en
prefLabel
Paula Da Fonseca
@en
da Fonseca P
@nl
P106
P31
P496
0000-0001-8656-5747